Placenta-Derived Solutions Transforming Pharmaceuticals and Anti-Aging Skincare
The global placenta market is experiencing significant growth, with projections indicating a rise from USD 85.52 billion in 2024 to approximately USD 1,404.87 million by 2034, reflecting a compound annual growth rate (CAGR) of 8.9% during the forecast period.
Market
Overview
Placental-derived
products have gained prominence across various industries due to their rich
composition of bioactive compounds, including growth factors, hormones, and
proteins. These components contribute to the therapeutic and cosmetic benefits
of placenta-based products, leading to increased adoption in pharmaceuticals,
cosmetics, and nutraceuticals.
Market
Segmentation
By
Type:
- Porcine
Placenta: Derived
from pigs, porcine placenta is rich in growth factors and proteins, making
it highly valued in both pharmaceuticals and cosmetics. Its regenerative
properties are utilized in skin regeneration and anti-aging products.
- Equine
Placenta:
Sourced from horses, equine placenta is primarily used in premium cosmetic
products and therapeutic treatments. It is appreciated for its high levels
of growth factors and amino acids that enhance skin rejuvenation and
repair.
- Ovine
Placenta:
Obtained from sheep, ovine placenta is utilized in various applications
due to its beneficial properties.
By
Application:
- Pharmaceuticals: Placental extracts are explored
for their therapeutic properties, including liver function improvement and
treatment of menopausal symptoms.
- Cosmetics: The anti-aging and skin
rejuvenation properties of placenta extracts have led to their
incorporation in skincare products.
- Nutraceuticals: Placenta-based supplements are
gaining popularity for their potential health benefits.
𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞: https://www.polarismarketresearch.com/industry-analysis/placenta-market
Regional
Analysis
- North
America: The
region leads the global placenta market, driven by high demand for
placenta-based cosmetics, health supplements, and pharmaceutical products.
- Asia-Pacific: Expected to register the highest
CAGR in the coming years, attributed to the rising prevalence of rare
diseases and growing demand for placenta-based supplements.
- Europe: Countries like Germany, France,
and the UK are witnessing increased adoption of placenta-derived products
in cosmetics and healthcare.
- Latin
America and Middle East & Africa: These regions are emerging markets for placenta
products, with growing awareness and acceptance contributing to market
expansion.
Key
Companies
Several
companies are actively involved in the development and commercialization of
placenta-derived products:
- Japan
Bio Products Co., Ltd.:
Engaged in the research, development, manufacturing, and distribution of
pharmaceutical, cosmetic, and healthcare products derived from human
placental extracts.
- Japan
Natural Laboratories Co., Ltd.:
Specializes in the manufacture and sale of quasi-drugs, cosmetics, and
health foods, leveraging expertise in pharmaceutical and cosmetic
manufacturing.
- Albert
David Limited: An
Indian pharmaceutical company producing placenta-based products for
therapeutic applications.
- MIMEDX
Group, Inc.: Focuses
on placental tissue-based regenerative medicine and wound care solutions.
- PURTIER
Placenta: Offers
placenta-based supplements aimed at promoting health and wellness.
Conclusion
The
global placenta
market is poised for substantial growth, driven by increasing demand across
pharmaceuticals, cosmetics, and nutraceuticals. Advancements in research and
development, coupled with rising consumer awareness of the benefits of
placenta-derived products, are expected to further propel market expansion in
the coming years.
More
Trending Latest Reports By Polaris Market Research:
Built
And Natural Environment Consulting Market
High
Purity Silica Sand for Solar Cell Market
Comments
Post a Comment